Skip to content
Study details
Enrolling now

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management

Ying Liu
NCT IDNCT04130464ClinicalTrials.gov data as of Apr 2026
Phase

Phase 4

Ages

18–65

Sex

Female only

Locations

2 sites in DC

What this study is about

This Phase 4 study is testing Ketorolac Infusion from ON-Q Pump in people with gynecologic surgical procedures. The primary outcome being measured is Pain Level 1 Hour Postoperative.

Simplified from trial records by PatientMatch.

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Injection / IVInjection / IV

How treatment is administered

Treatment Assignment
Standard assignment

Assignment is predetermined by the study protocol.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

ropivacaine, NERVOUS SYSTEM

Drug routes

infusion

Endpoints

Primary: Pain Level 1 Hour Postoperative, Pain Level 2 Hours Postoperative, Pain Level 24 Hours Postoperative, Pain Level 4 Hours Postoperative, Pain Level 48 Hours Postoperative, Pain Level 6 Hours Postoperative, Pain Level 72 Hours Postoperative

Devices

therapeutic